Follicular lymphoma

Follicular lymphoma (FL) is one of the most common forms of non-Hodgkin's lymphomas, characterized by a slow but progressive course and high recurrence rates. This neoplastic disease arises from the follicular zone of lymphatic tissue and is associated mainly with disorders of B-lymphocytes. Follicular lymphoma most often manifests itself as enlarged lymph nodes, but can also affect other organs, such as the liver, spleen, and bone marrow. The disease is benign in the early stages, but can develop into an aggressive form, which requires a comprehensive approach to treatment and monitoring of the patient's condition.

History of the disease and interesting historical facts

The history of follicular lymphoma goes back more than a century, starting with the first mentions of lymphomas in the early 20th century. In 1944, scientists established that lymphomas can be classified into several types, including follicular lymphoma. In 1982, the main pathogenetic mechanism associated with a chromosomal translocation was established, which was described as t(14;18). This translocation leads to activation of the BCL2 gene, which becomes a key factor in the pathogenesis of the disease. An interesting fact is that follicular lymphoma, despite its relative benignity, can progress to more aggressive forms, such as diffuse large cell lymphoma. Research continued to deepen, and today follicular lymphoma is considered a complex disease that requires an individualized approach to treatment.

Epidemiology

Follicular lymphoma is an important medical problem given its high prevalence. According to various epidemiological studies, the incidence of follicular lymphoma in the northern hemisphere varies from 2 to 6 cases per 100,000 population per year. This disease most often affects people over 50 years old, the average age of diagnosis is about 60 years. In addition, there is a slight predisposition of men to this disease compared to women. In general, against the background of the general increase in the incidence of non-Hodgkin's lymphomas, follicular lymphoma seems to be one of the most noticeable forms.

Genetic predisposition to this disease

Genetic predisposition to follicular lymphoma is determined by a number of factors associated with abnormalities in the structure and function of certain genes. An important role is played by chromosomal abnormalities, especially the t(14;18) translocation, which leads to activation of the BCL2 gene. As a result of this process, apoptosis of B lymphocytes is suppressed, which contributes to their endless proliferation and tumor formation. Other genes involved may include TP53, MYC, and others that are involved in cell cycle regulation and control of apoptosis. According to current research, BCL2 translocation is observed in 70-90% cases of follicular lymphoma, indicating its key role in the pathogenesis of this disease.

Risk factors for the development of this disease

There are several risk factors that may contribute to the development of follicular lymphoma:

• Age: The incidence increases with age, especially after 50 years.
• Gender: Men have a slightly higher risk than women.
• Immunodeficiency: Individuals with weakened immune systems, such as those with human immunodeficiency virus (HIV), have an increased risk of developing lymphomas.
• Autoimmune diseases: Some studies suggest a link between autoimmune conditions and the development of lymphomas.
• Environmental factors: The possible influence of certain chemicals and pesticides on the risk of developing lymphoma has not been definitively established, but requires further study.

Diagnosis of this disease

Diagnosis of follicular lymphoma involves several key steps:

• The main symptoms are swollen lymph nodes, night sweats, mild confusion, weakness and weight loss.
• Laboratory tests: Blood tests to check for abnormal cells, lactate dehydrogenase (LDH) levels, and lymph node biopsy for histologic and immunohistochemical examination.
• Radiological examinations: computed tomography (CT) and PET-CT to assess the extent of the disease.
• Other types of diagnostics: MRI and ultrasound to study the condition of internal organs.
• Differential diagnosis: It is important to exclude other types of lymphomas and diseases such as chronic lymphoproliferative disorders.

Treatment

Treatment of follicular lymphoma requires an individual approach and may include various methods:

• General treatment: Depending on the stage of the disease, observation without treatment may be recommended if the disease is mild.
• Pharmacological treatment: The standard of treatment is chemotherapy combined with monoclonal antibodies such as rituximab.
• Surgery: Surgery may be performed to remove limited tumor, especially when the lymphoma is localized.
• Other treatments: Radiotherapy is used in later stages or as maintenance therapy.

List of medications used to treat this disease

The main drugs used to treat follicular lymphoma include:

• Rituximab
• Cyclophosphamide
• Doxorubicin
• Vincristine
• Prednisone

Disease monitoring

Monitoring of patients with follicular lymphoma includes regular follow-up examinations to assess disease progression:

• Control stages: regular examinations by an oncologist, CT and PET-CT as needed.
• Prognosis: Overall, the prognosis for patients with follicular lymphoma is considered good, but as the disease progresses, the prognosis may worsen.
• Complications: possible relapse of the disease, side effects from chemotherapy and development of secondary tumors.

Age-related features of the disease

Follicular lymphoma has its own characteristics of the course in different age groups:

• In patients under 50 years of age, the disease may be more aggressive and require intensive treatment.
• Older people tend to have a slower progression of the disease, but the risk of comorbidities may complicate the approach to diagnosis and treatment.
• In pediatric practice, follicular lymphoma is extremely rare, but also requires a special approach and specialized treatment.

Questions and Answers

• What is follicular lymphoma? Follicular lymphoma is a benign form of lymphoma that arises from B lymphocytes and is characterized by slow progression.
• How is this disease diagnosed? Diagnosis is based on symptoms, laboratory test results and radiological examination.
• What is the treatment for follicular lymphoma? Treatment may include observation, chemotherapy, monoclonal antibodies, and in some cases radiation therapy or surgery.
• What is the prognosis for follicular lymphoma? The prognosis depends on the stage of the disease, but is generally considered favorable if the disease is successfully controlled.
• Can I exercise if I have follicular lymphoma? Physical activity is acceptable, but you should consult your doctor for an individual assessment of your condition.

Advice from Dr. Oleg Korzhikov

Dr. Oleg Korzhikov notes that patients with follicular lymphoma should closely monitor their condition and undergo regular examinations:

• Stay in touch with your oncologist for up-to-date information on your treatment and progress.
• Monitor your health for changes and report any new symptoms to your doctor.
• Maintain a healthy lifestyle: A balanced diet, physical activity and stress management can help improve your overall health.

This information is general and does not replace consultation with a doctor. If you suspect that you may have follicular lymphoma or any other disease, consult a specialist for a detailed evaluation and diagnosis.